JACOBS LEVY EQUITY MANAGEMENT, INC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 69 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,296,000
+143.6%
245,018
+114.1%
0.01%
+125.0%
Q1 2021$532,000
+40.7%
114,4390.0%0.00%
+33.3%
Q4 2020$378,000
+250.0%
114,439
+822.9%
0.00%
+50.0%
Q1 2018$108,00012,4000.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ETF MANAGERS GROUP, LLC 3,662,342$7,874,0000.16%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 213,469$438,0000.07%
GSA CAPITAL PARTNERS LLP 150,914$309,0000.04%
Bernardo Wealth Planning LLC 30,469$62,0000.03%
Penserra Capital Management LLC 351,154$719,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,900$361,0000.01%
Founders Capital Management 3,000$9,0000.01%
Aquatic Capital Management LLC 1,900$4,0000.01%
Newbridge Financial Services Group, Inc. 6,075$12,0000.01%
King Wealth Management Group 16,000$33,0000.01%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders